Leukemia drug passes final trial phase with flying colors
A medication to treat chronic myeloid leukemia (CML) has shown its potential to become the new frontline therapy for people living with the life-threatening blood cancer.
Jun 4, 2024
0
38
Pathological Conditions, Signs and Symptoms: News and Research on Leukemia, Myelogenous, Chronic, BCR-ABL Positive
MeSH tree: C23.550.291.500.485
Clues to cancer drug's deadly side effects could make it safer
For some leukemia patients, the only potential chemotherapy option is a drug that also carries a high risk of heart failure. This means that some patients who recover from their cancer will end up dying of heart disease brought ...
Feb 8, 2024
0
68
Key signaling protein identified as possible target for new therapies in hard-to-treat cancers
The unique signaling protein known as TRPM7 can stimulate and interact with an important cellular signaling hub called the AKT machinery, which is a well-known component of multiple cellular functions that drive growth and ...
Oct 26, 2023
0
43
Closing in on a cure for common leukemia
A leukemia test can help identify patients who are strong candidates for lifelong treatment free remission (TFR)—meaning they are effectively cured of the disease.
Sep 12, 2023
0
59
Mast cells shown to have an important impact on the development of chronic myeloid leukemia
Chronic myeloid leukemia (CML) is a type of blood cancer that arises from malignant changes in blood-forming cells of the bone marrow. It mainly occurs in older individuals and represents about 20% of all adult leukemia cases.
May 16, 2023
0
80
Drug form of traditional Chinese medicine compound found to improve survival of mice with brain tumors
A new study shows how a drug made from a natural compound used in traditional Chinese medicine works against malignant brain tumors in mice, creating a promising avenue of research for glioblastoma treatment.
Apr 14, 2023
0
134
New therapy could help chronic myeloid leukemia patients live drug-free
The latest research from SAHMRI and the University of Adelaide has discovered a potential new therapy for chronic myeloid leukemia (CML) patients who've achieved excellent results from current treatment and are hoping to ...
Mar 1, 2023
0
138
Researchers use a new approach to hit an 'undruggable' target
The protein STAT5 has long been an appealing target against cancer, but after decades of research it was consigned to the "undruggable" category. Now, University of Michigan Rogel Cancer Center researchers have found success ...
Feb 15, 2023
0
76
Are drug companies the villain? New study questions claims of 'evergreening'
For years, brand drug companies have been villainized for "evergreening" or manipulating the law to extend the period of exclusivity for drugs beyond their 20-year patent—a practice critics say unfairly prevents competition ...
Nov 3, 2022
0
47
First-ever licencing deal struck for cancer drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
Oct 20, 2022
0
29
